Pentwater Capital Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,125
| Closed | -$495K | – | 107 |
|
|
2022
Q4 | $495K | Buy |
+3,125
| New | +$495K | 0.01% | 75 |
|
|
2022
Q1 | – | Sell |
-14,375
| Closed | -$4.22M | – | 156 |
|
|
2021
Q4 | $4.22M | Hold |
14,375
| – | – | 0.05% | 69 |
|
|
2021
Q3 | $3.57M | Buy |
14,375
+1,250
| +10% | +$311K | 0.04% | 86 |
|
|
2021
Q2 | $3.34M | Buy |
13,125
+9,375
| +250% | +$2.38M | 0.03% | 95 |
|
|
2021
Q1 | $666K | Sell |
3,750
-1,250
| -25% | -$222K | 0.01% | 195 |
|
|
2020
Q4 | $790K | Hold |
5,000
| – | – | 0.01% | 134 |
|
|
2020
Q3 | $1.29M | Buy |
5,000
+438
| +10% | +$113K | 0.02% | 111 |
|
|
2020
Q2 | $1.06M | Buy |
4,562
+153
| +3% | +$35.5K | 0.02% | 76 |
|
|
2020
Q1 | $750K | Buy |
+4,409
| New | +$750K | 0.01% | 68 |
|